PAM
LUMO

Paradigm Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Paradigm Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,078
Closed -$386K – 851
2014
Q4 		$386K Sell
1,078
-1,055
-49% -$314K 0.05% 364
2014
Q3 		$411K Sell
2,133
-200
-9% -$44K 0.06% 340
2014
Q2 		$558K Buy
2,333
+566
+32% +$115K 0.08% 295
2014
Q1 		$452K Sell
1,767
-133
-7% -$40.7K 0.06% 331
2013
Q4 		$376K Sell
1,900
-133
-7% -$23.7K 0.06% 377
2013
Q3 		$344K Buy
+2,033
New +$327K 0.06% 376

Other funds holding LUMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Paradigm Asset Management's LUMO Position: Q1 2015 in Review

Paradigm Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2015, closing a stake of 1,078 shares — an estimated $386K sold.

Paradigm Asset Management first reported a position in LUMO in Q3 2013 and held it in 6 quarters. The position peaked at $558K in Q2 2014. 124 funds tracked by Wall St. Rank hold LUMO as of Q1 2015.

  • Paradigm Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Paradigm Asset Management sold 1,078 Lumos Pharma, Inc. Common Stock shares in Q1 2015, an estimated $386K.
  • Paradigm Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2013 and held it in 6 quarters.
  • Paradigm Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $558K in Q2 2014.
  • 124 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2015.

Based on Paradigm Asset Management's 13F filing for Q1 2015, filed 14 May 2015.